Inositol Treatment in Different Type of PCOS Phenotype

Lo.Li.Pharma s.r.l120 enrolled

Overview

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

120

Conditions

Polycystic Ovary Syndrome

Interventions

Myo-inositolDIETARY_SUPPLEMENT

Myo-inositol (4g/die)

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women with PCOS of any phenotype Exclusion Criteria: * hormonal treatment (such as contraceptive pill) * use of supplements containing myo-inositol * severe co-morbidities

Locations (1)

Clinica Alma Res

Roma, Italy

Outcomes

Primary Outcomes

Regularization of the menstrual cycle

Number of women with regular/altered menstrual cycle

Time frame: Change from baseline number of women with irregular menstrual cycle at 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.